https://www.marketscreener.com/quote/stock/FORESEE-PHARMACEUTICALS-C-45304233/news/Foresee-Pharmaceuticals-to-Present-Phase-1-2-Fanconi-Anemia-Clinical-Study-Design-for-its-ALDH2-acti-44964890/?utm_source=telegram&utm_medium=social&utm_campaign=share